According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of its kind and marks a turning point in the ...

Bringing a medical device to market typically takes 3 to 7 years, with clinical investigations being the most time-consuming and costly phase. Every clinical trial begins with the development of a ...

Several ASX-listed companies are making significant strides in their phase III clinical trials, the critical final stage ...

UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary incontinence (SUI), ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Sedana Medical AB (publ) announces that its second pivotal US trial INSPiRE-ICU 2 has met its primary endpoint, and hence established non-inferiority of inhaled sedation with isoflurane compared with ...

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.11 million, is ...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical trial of sparsentan for the ...